The “Maximize Profits” Trap in Decision Making
Harvard Business
SEPTEMBER 19, 2016
Imagine, for example, that you’re a pharmaceutical CEO deciding whether to recall a new drug. “When we work on making our devices accessible by the blind,” he added, “I don’t consider the bloody ROI.” With gray area problems, you have to look hard at the economics and look past the economics.
Let's personalize your content